Works matching IS 13518216 AND DT 2018 AND VI 24 AND IP 5

Results: 34

Congenital coagulation factor X deficiency: Genetic analysis of five patients and functional characterization of mutant factor X proteins.

Published in:

Haemophilia, 2018, v. 24, n. 5, p. 774, doi. 10.1111/hae.13606

By:

Nagaya, Satomi;
Murakami, Morika;
Sekiya, Akiko;
Morishita, Eriko;
Akiyama, Masashi;
Asakura, Hidesaku

Publication type:

Article

Efficacy and safety of low‐dose prophylaxis of highly purified plasma‐derived factor VIII concentrate produced by the National Blood Centre, Thai Red Cross Society.

Published in:

Haemophilia, 2018, v. 24, n. 5, p. e387, doi. 10.1111/hae.13601

By:

Factor VIII Study Group;
Chuansumrit, Ampaiwan;
Sosothikul, Darintr;
Natesirinilkul, Rungrote;
Lektrakul, Yujinda;
Charoonruangrit, Ubonwon

Publication type:

Article

Pain assessment and management in haemophilia: A survey among Italian patients and specialist physicians.

Published in:

Haemophilia, 2018, v. 24, n. 5, p. 766, doi. 10.1111/hae.13600

By:

the ad hoc Study Group;
Tagliaferri, Annarita;
Rivolta, Gianna F.;
Quintavalle, Gabriele;
Coppola, Antonio;
Franchini, Massimo;
Farace, Stefania

Publication type:

Article

Retrospective review of Acquired Haemophilia A from the largest Canadian Haemophilia treatment centre.

Published in:

Haemophilia, 2018, v. 24, n. 5, p. e383, doi. 10.1111/hae.13598

By:

Jayakar, Jai P.;
Garvey, Marie B.;
O'Neill, Natalya;
Teitel, Jerome;
Sholzberg, Michelle;
Yan, Marie;
Nisenbaum, Rosane

Publication type:

Article

Evaluating the thrombin generation profiles of four different rFVIII products in FVIII‐deficient plasma using FIXa and FXIa activation.

Published in:

Haemophilia, 2018, v. 24, n. 5, p. 815, doi. 10.1111/hae.13597

By:

Brophy, Donald F.;
Martin, Erika J.;
Mohammed, Bassem M.;
Ninivaggi, Marisa;
Waters, Emily K.;
Ezban, Mirella;
Barrett, John C.;
Kuhn, Janice;
Nolte, Melinda E.

Publication type:

Article

Real‐world comparative analysis of bleeding complications and health‐related quality of life in patients with haemophilia A and haemophilia B.

Published in:

Haemophilia, 2018, v. 24, n. 5, p. e322, doi. 10.1111/hae.13596

By:

Booth, Jason;
Oladapo, Abiola;
Walsh, Shaun;
O'Hara, Jamie;
Carroll, Liz;
Garcia Diego, Daniel‐Anibal;
O'Mahony, Brian

Publication type:

Article

Rate and appropriateness of polypharmacy in older patients with hemophilia compared with age‐matched controls.

Published in:

Haemophilia, 2018, v. 24, n. 5, p. 726, doi. 10.1111/hae.13595

By:

Mannucci, Pier Mannuccio;
Santoro, Cristina;
Ettorre, Cosimo;
Zanon, Ezio;
Barillari, Giovanni;
Cantori, Isabella;
Caimi, Teresa Maria;
Sottilotta, Gianluca;
Iorio, Alfonso;
Nobili, Alessandro;
Cortesi, Laura;
Marchesini, Emanuela;
Oliovecchio, Emily;
Coppola, Antonio;
Tagliaferri, Annarita;
Santagostino, Elena;
Peyvandi, Flora;
Radossi, Paolo;
Castaman, Giancarlo;
Valdrè, Lelia

Publication type:

Article

Perioperative haemostasis in children with haemophilia and inhibitors during central venous catheter surgery: The Karolinska model.

Published in:

2018

By:

Hägglöf, Helena;
Petrini, Pia;
Frisk, Tony;
Ranta, Susanna;
Magnusson, Maria

Publication type:

Letter to the Editor

UK Haemophilia Centre Doctors’ Organisation guidance on the use of extended‐half‐life coagulation factor concentrates in routine clinical practice: Report of a meeting on their adoption by Belgian haemophilia treaters.

Published in:

2018

By:

Hermans, Cedric;
Van Damme, An;
Dolan, Gerry;
Maes, Philip;
Peerlinck, Kathelijne

Publication type:

Letter to the Editor

Application of optimized nursing process to perioperative patients with haemophilic pseudotumours.

Published in:

2018

By:

Chen, Yaping;
He, Yu;
Zhou, Xi;
Xu, Yuan;
Zhang, Baozhong;
Liu, Yong;
Weng, Xisheng

Publication type:

Letter to the Editor

Impact of target joint and FVIII inhibitor οn bone properties in children with haemophilia A: A peripheral quantitative computed tomography study.

Published in:

Haemophilia, 2018, v. 24, n. 5, p. 800, doi. 10.1111/hae.13591

By:

Xafaki, Panagiota;
Pergantou, Helen;
Platokouki, Helen;
Papakonstantinou, Olympia;
Balanika, Alexia

Publication type:

Article

The sudden and unexpected appearance of inhibitors in a previously treated severe haemophilia B patient after the switch to albutrepenonacog alpha.

Published in:

2018

By:

Zanon, Ezio;
Pasca, Samantha;
Simioni, Paolo

Publication type:

Letter to the Editor

Value of prophylaxis vs on‐demand treatment: Application of a value framework in hemophilia.

Published in:

Haemophilia, 2018, v. 24, n. 5, p. 755, doi. 10.1111/hae.13589

By:

on behalf of the International Haemophilia Access Strategy Council;
Nugent, Diane;
O'Mahony, Brian;
Dolan, Gerry

Publication type:

Article

Positioning extended half‐life concentrates for future use: a practical proposal.

Published in:

2018

By:

“OPTI‐CLOT" study group;
Nederlof, Angelique;
Cnossen, Marjon H.;
Mathôt, Ron A. A.;
Leebeek, Frank W. G.;
Fijnvandraat, Karin;
Fischer, Kathelijn

Publication type:

Letter to the Editor

Desmopressin in non‐severe haemophilia A: Test‐response and clinical outcomes in a single Canadian centre review.

Published in:

Haemophilia, 2018, v. 24, n. 5, p. 720, doi. 10.1111/hae.13586

By:

Hews‐Girard, Julia;
Rydz, Natalia;
Lee, Adrienne;
Goodyear, Marilyn Dawn;
Poon, Man‐Chiu

Publication type:

Article

Risk factors for cardiovascular disease in children and young adults with haemophilia.

Published in:

Haemophilia, 2018, v. 24, n. 5, p. 747, doi. 10.1111/hae.13585

By:

Limjoco, Jacqueline;
Thornburg, Courtney D.

Publication type:

Article

Review of molecular mechanisms at distal Xq28 leading to balanced or unbalanced genomic rearrangements and their phenotypic impacts on hemophilia.

Published in:

Haemophilia, 2018, v. 24, n. 5, p. 711, doi. 10.1111/hae.13569

By:

Lannoy, N.;
Hermans, C.

Publication type:

Article

Effectiveness of a comprehensive educational programme for Accredited Social Health Activists (ASHAs) to identify individuals in the Udupi district with bleeding disorders: A community‐based survey.

Published in:

Haemophilia, 2018, v. 24, n. 5, p. 741, doi. 10.1111/hae.13567

By:

Badagabettu, S.;
George, A.;
Nayak, D. M.;
Kurien, A.;
Kamath, V. G.;
Kamath, A.

Publication type:

Article

Clinical and radiologic results after open‐wedge high tibial osteotomy in haemophilic knee arthropathy with varus deformity.

Published in:

Haemophilia, 2018, v. 24, n. 5, p. 792, doi. 10.1111/hae.13566

By:

Cho, Y. J.;
Song, S. J.;
Rhyu, K. H.;
Jang, T. S.;
Park, C. H.

Publication type:

Article

Distinguishing lupus anticoagulants from factor VIII inhibitors in haemophilic and non‐haemophilic patients.

Published in:

Haemophilia, 2018, v. 24, n. 5, p. 807, doi. 10.1111/hae.13565

By:

Rampersad, A. G.;
Shapiro, A.;
Boylan, B.;
Miller, C. H.

Publication type:

Article

Factor VIII activity of BAY 94‐9027 is accurately measured with most commonly used assays: Results from an international laboratory study.

Published in:

Haemophilia, 2018, v. 24, n. 5, p. 823, doi. 10.1111/hae.13564

By:

Church, N.;
Michaels, L. A.;
Leong, L.;
Katterle, Y.;
Ulbrich, H.‐F.;
Noerenberg, I.;
Kitchen, S.

Publication type:

Article

Clinical relevance of 3D gait analysis in patients with haemophilia.

Published in:

Haemophilia, 2018, v. 24, n. 5, p. 703, doi. 10.1111/hae.13563

By:

Fouasson‐Chailloux, A.;
Menu, P.;
Dauty, M.;
Vinatier, C.;
Guicheux, J.;
Maugars, Y.;
Trossaert, M.;
Rannou, F.

Publication type:

Article

BAY 94‐9027, a PEGylated recombinant factor VIII, exhibits a prolonged half‐life and higher area under the curve in patients with severe haemophilia A: Comprehensive pharmacokinetic assessment from clinical studies.

Published in:

Haemophilia, 2018, v. 24, n. 5, p. 733, doi. 10.1111/hae.13561

By:

Shah, A.;
Michaels, L. A.;
Coyle, T.;
Lalezari, S.;
Fischer, K.;
Kohlstaedde, B.;
Delesen, H.;
Radke, S.

Publication type:

Article

Clinical outcomes and patient satisfaction following total hip and knee arthroplasty in patients with inherited bleeding disorders: A 20‐year single‐surgeon cohort.

Published in:

Haemophilia, 2018, v. 24, n. 5, p. 786, doi. 10.1111/hae.13559

By:

Anderson, J. A.;
Halliday, B.;
Mason, J. A.

Publication type:

Article

Potency estimates for recombinant factor IX in the one‐stage clotting assay are influenced by more than just the choice of activated partial thromboplastin time reagent.

Published in:

Haemophilia, 2018, v. 24, n. 5, p. e363, doi. 10.1111/hae.13556

By:

Wilmot, Helen V.;
Gray, Elaine

Publication type:

Article

In silico and in vitro immunogenicity assessment of B‐domain‐modified recombinant factor VIII molecules.

Published in:

Haemophilia, 2018, v. 24, n. 5, p. e354, doi. 10.1111/hae.13555

By:

Bartholdy, C.;
Reedtz‐Runge, S. L.;
Wang, J.;
Hjerrild Zeuthen, L.;
Gruhler, A.;
Gudme, C. N.;
Lamberth, K.

Publication type:

Article

Recommendations on multidisciplinary management of elective surgery in people with haemophilia.

Published in:

Haemophilia, 2018, v. 24, n. 5, p. 693, doi. 10.1111/hae.13549

By:

Escobar, M. A.;
Rodriguez‐Merchan, E. C.;
Shapiro, A.;
Solimeno, L. P.;
Brewer, A.;
Caviglia, H.;
Forsyth, A.;
Jimenez‐Yuste, V.;
Laudenbach, L.;
Lobet, S.;
McLaughlin, P.;
Oyesiku, J. O. O.

Publication type:

Article

Emotional distress in haemophilia: Factors associated with the presence of anxiety and depression symptoms among adults.

Published in:

Haemophilia, 2018, v. 24, n. 5, p. e344, doi. 10.1111/hae.13548

By:

Pinto, P. R.;
Paredes, A. C.;
Moreira, P.;
Almeida, A.;
Fernandes, S.;
Lopes, M.;
Carvalho, M.

Publication type:

Article

Long‐term outcomes from prophylactic or episodic treatment of haemophilia A: A systematic review.

Published in:

Haemophilia, 2018, v. 24, n. 5, p. e301, doi. 10.1111/hae.13546

By:

O'Hara, J.;
Sima, C. S.;
Frimpter, J.;
Paliargues, F.;
Chu, P.;
Presch, I.

Publication type:

Article

Abnormal coagulation and enhanced fibrinolysis due to lysinuric protein intolerance associates with bleeds and renal impairment.

Published in:

Haemophilia, 2018, v. 24, n. 5, p. e312, doi. 10.1111/hae.13543

By:

Pitkänen, H. H.;
Lassila, R.;
Kärki, M.;
Näntö‐Salonen, K.;
Niinikoski, H.;
Tanner, L.;
Pikta, M.;
Kopatz, W. F.;
Meijers, J. C. M.;
Zuurveld, M.;
Brinkman, H. J. M.

Publication type:

Article

Improvement in clinical outcomes and replacement factor VIII use in patients with haemophilia A after factor VIII pharmacokinetic‐guided prophylaxis based on Bayesian models with myPKFiT<sup>®</sup>.

Published in:

Haemophilia, 2018, v. 24, n. 5, p. e338, doi. 10.1111/hae.13540

By:

Mingot‐Castellano, M. E.;
Parra, R.;
Martorell, M.;
Núñez, R.

Publication type:

Article

The Japanese Immune Tolerance Induction (J‐ITI) study in haemophilia patients with inhibitor: Outcomes and successful predictors of ITI treatment.

Published in:

Haemophilia, 2018, v. 24, n. 5, p. e328, doi. 10.1111/hae.13531

By:

Nogami, K.;
Shima, M.;
Taki, M.;
Matsushita, T.;
Ohga, S.;
Oka, T.;
Horikoshi, Y.;
Amano, K.

Publication type:

Article

Issue Information.

Published in:: 2018
Publication type:: Table of Contents

Instructions for Authors.

Published in:: Haemophilia, 2018, v. 24, n. 5, p. 833, doi. 10.1111/hae.13340
Publication type:: Article